My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 148

    1.

    Serum biomarkers in interstitial lung diseases.

    Tzouvelekis A, Kouliatsis G, Anevlavis S, Bouros D.

    Respir Res. 2005 Jul 21;6:78. Review.PMID: 16042760 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator.

    Tzouvelekis A, Pneumatikos I, Bouros D.

    Respir Res. 2005 Jun 22;6:62. Review.PMID: 15972108 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.

    Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR, Fertig N, Oddis CV, Kaminski N, Rosas IO, Ascherman DP.

    Arthritis Rheum. 2009 Jul;60(7):2183-92.PMID: 19565490 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology.

    Müller-Quernheim J.

    Sarcoidosis Vasc Diffuse Lung Dis. 1998 Mar;15(1):22-37. Review.PMID: 9571999 [PubMed - indexed for MEDLINE]Related articles

    6.

    Proteomic analysis in interstitial lung diseases: a review.

    Rottoli P, Bargagli E, Landi C, Magi B.

    Curr Opin Pulm Med. 2009 Sep;15(5):470-8. Review.PMID: 19593140 [PubMed - indexed for MEDLINE]Related articles

    7.

    Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.

    Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, Elashoff R, Tashkin DP, Silver RM; Scleroderma Lung Study Research Group.

    J Rheumatol. 2009 Apr;36(4):773-80. Epub 2009 Mar 13.PMID: 19286849 [PubMed - indexed for MEDLINE]Related articles

    8.

    Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.

    Kolarcik C, Bowser R.

    Mol Diagn Ther. 2006;10(5):281-92. Review.PMID: 17022691 [PubMed - indexed for MEDLINE]Related articles

    9.

    Spectrum of fibrosing diffuse parenchymal lung disease.

    Morgenthau AS, Padilla ML.

    Mt Sinai J Med. 2009 Feb;76(1):2-23. Review.PMID: 19170214 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Interstitial pneumonitis and serum markers (SP-D & KL-6) in collagen vascular diseases]

    Sagawa A.

    Nihon Rinsho Meneki Gakkai Kaishi. 2004 Apr;27(2):55-63. Review. Japanese. No abstract available. PMID: 15164926 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [Diffuse lung diseases and biological markers in serum]

    Takahashi H, Shiratori M.

    Nippon Naika Gakkai Zasshi. 2006 Jun 10;95(6):986-92. Review. Japanese. No abstract available. PMID: 16846044 [PubMed - indexed for MEDLINE]Related articles

    12.

    Proteomics and opportunities for clinical translation in urological disease.

    Vaezzadeh AR, Steen H, Freeman MR, Lee RS.

    J Urol. 2009 Sep;182(3):835-43. Epub 2009 Jul 17. Review.PMID: 19616261 [PubMed - indexed for MEDLINE]Related articles

    13.

    Gefitinib-induced interstitial lung disease showing improvement after cessation: disassociation of serum markers.

    Kitajima H, Takahashi H, Harada K, Kanai A, Inomata S, Taniguchi H, Saikai T, Abe S.

    Respirology. 2006 Mar;11(2):217-20.PMID: 16548909 [PubMed - indexed for MEDLINE]Related articles

    14.

    Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.

    Bharti A, Ma PC, Salgia R.

    Mass Spectrom Rev. 2007 May-Jun;26(3):451-66. Review.PMID: 17407130 [PubMed - indexed for MEDLINE]Related articles

    15.

    Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.

    Sinchaikul S, Hongsachart P, Sriyam S, Tantipaiboonwong P, Phutrakul S, Chen ST.

    Chang Gung Med J. 2008 Sep-Oct;31(5):417-30. Review.PMID: 19097588 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    New developments in scleroderma interstitial lung disease.

    Highland KB, Silver RM.

    Curr Opin Rheumatol. 2005 Nov;17(6):737-45. Review.PMID: 16224252 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Respiratory tract diseases and pulmonary surfactant protein molecules]

    Abe S, Shiratori S, Takahashi H.

    Nippon Naika Gakkai Zasshi. 2002 Sep 20;91 Suppl:236-42. Review. Japanese. No abstract available. PMID: 12580123 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Interstitial lung disease: auto-antibodies in routine practice]

    Papo T.

    Rev Pneumol Clin. 2005 Jun;61(3):171-8. Review. French. PMID: 16142190 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems.

    Lainscak M, Anker SD.

    Herz. 2009 Mar;34(2):141-7. Review.PMID: 19370331 [PubMed - indexed for MEDLINE]Related articles

    20.

    Biomarkers for malignant pleural mesothelioma: current status.

    Greillier L, Baas P, Welch JJ, Hasan B, Passioukov A.

    Mol Diagn Ther. 2008;12(6):375-90. doi: 10.2165/1250444-200812060-00004. Review.PMID: 19035624 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk